Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Azenta Life Sciences Names Matthew McManus Chief Operating Officer
Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th. In […]
Abbott Announces Future of Biowearables at Consumer Electronics Show
Making CES history, Abbott (NYSE: ABT) presented a keynote at the most influential tech event in the world, […]
Elekta to Appoint Tobias Hägglöv as Chief Financial Officer
Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer […]
Neurimmune Enters into a Collaboration and License Agreement with AstraZeneca to Develop and Commercialize NI006
Neurimmune AG today announced that it has entered into an exclusive global collaboration and license […]
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem […]
Future Fertility Raises Series A to Progress First-In-Class AI-Enabled Fertility Solutions to Improve IVF Outcomes
Future Fertility, a fertility technology company developing AI-enabled and non-invasive fertility solutions to optimize clinical […]
Samsara Therapeutics Establishes Scientific Advisory Board
Samsara Therapeutics Inc. (Samsara), a discovery-stage biotech with a world-leading screening platform for inducers of […]
Univercells Acquires SynHelix, Entering into Synthetic Biology and the Race to Next-generation DNA Synthesis
Univercells S.A. (Univercells) today announces its acquisition of SynHelix, a biotechnology company that aims to debottleneck […]
SomaLogic Announces Exclusive Partnership with Illumina to Develop Sequencing-based Proteomic Solutions
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration […]
Anthos Therapeutics Appoints David McIntyre as Chief Financial Officer
Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more